Growth Hormone in Korea: Who Actually Gets Prescribed It

Yes — And That Is Exactly Why the Question Matters

Growth hormone is prescribed widely in Korea, and coverage of that fact in the press is what most people outside the country have read. What the coverage rarely explains is who it is actually for.

There is a clear line between a diagnosed medical condition and an elective request to be taller, and the two are treated differently — clinically and administratively.

Families arriving from abroad usually want to know which side of that line their child falls on. That is a testable question, not an opinion.

The Covered Side — A Diagnosis, Not a Height

Korea’s national health insurance covers growth hormone treatment when a recognised medical condition is diagnosed. The conditions are specific, and the criteria are set nationally rather than by each clinic.

Growth hormone deficiency is the clearest case: the body is not producing enough, and replacing it treats the deficiency. Certain chromosomal and developmental conditions, and children born small for gestational age who have not caught up, are also recognised.

What matters is that all of these are diagnoses. Being short is not one — a child in the lowest percentiles with no underlying condition does not qualify on height alone.

The Elective Side — And What It Is Reasonable to Expect

Outside those criteria, treatment is possible but paid privately, and this is where families deserve a straight answer.

The evidence for growth hormone in children who are short without a deficiency is more modest than the enthusiasm around it suggests. It is not nothing, and it is not the transformation the number of headlines implies.

Which is why the useful conversation is not «can we get it» — in a private setting the answer is often yes — but «what would it actually do for this child, and is there something else limiting growth that would do more».

Any clinic promising a specific number of centimetres is describing an outcome nobody can guarantee.

What Gets Checked Before Anything Is Prescribed

Regardless of which side a child falls on, the workup comes first.

• Bone age — a wrist X-ray showing how much growth plate remains
• Hormone panel — growth hormone markers, thyroid function, and where relevant sex hormones
• General blood work — liver and kidney function and blood glucose, which decide what is safe to prescribe
• Growth history — height over time, because velocity says more than a single measurement

These are repeated at intervals during treatment. A plan that is not working should be visible in the numbers within months, and that is the point of measuring rather than assuming.

Side Effects, Stated Plainly

Reactions at the injection site are the most common. Temporary headache or swelling have also been reported. Most of what is seen is mild.

The reason for scheduled re-testing is that changes in blood values can appear before anything is felt. If something is found, the plan is adjusted or stopped.

A clinic that will not discuss this plainly before starting is worth a second look. Treatment that runs for years should come with a stated stopping point.

What Families From Abroad Usually Want to Know First

Two questions come up almost every time.

Does our child qualify? That is answered by the workup above, and most of it can be done where you live — a local wrist X-ray and blood test, reviewed together on a video call.

Is it worth coming at all? Sometimes the honest answer is that there is time and nothing to start yet. Finding that out from home is a reasonable outcome, and it costs a local X-ray.

Whether treatment is appropriate, and by what method, is decided from test results and examination. The same approach is not applied to every child.